Skip to content

Clinical Study of Qingdai in Treatmenting Hand-foot Syndrome Induced by Anti-tumor Drugs

Clinical Study of Qingdai in Treatmenting Hand-foot Syndrome Induced by Anti-tumor Drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000958
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand-foot Syndrome Induced by Anti-tumor Drugs

Interventions

Control group:1/10 dose of the active ingredients of Qingdai is prepared by adding pigment and water, and the water decoction is soaked in hands and feet at 40? for external use
Treatment group:Qingdai water decoction 40? soak hands and feet for external use

Sponsors

Shanghai Fourth People's Hospital affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with malignant tumors confirmed by pathology or cytology; (2) Patients with grade I or above HFS after receiving chemotherapy or targeted therapy; (3) KPS score >60; (4) No serious dysfunction of heart liver kidney and other important organs; (5) Expected survival >3 months; (6) Age 18-80 years old; (7) Good compliance; (8) Voluntarily participate and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with serious diseases such as heart liver kidney and brain; (2) Patients with other types of diseases in the hands and feet; (3) People with allergies; (4) Currently participating in other Chinese and Western medicine treatment.

Design outcomes

Primary

MeasureTime frame
HF-QOL;HFS classification;

Secondary

MeasureTime frame
NRS;Inflammatory factor;MDASI-TCM;EORTC QOL C30;

Countries

China

Contacts

Public ContactJun Shi

Shanghai Fourth People's Hospital affiliated to Tongji University

shijundoctor@163.com13917311112

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026